Heartburn and acid reflux affect a large proportion of pregnant women, and for many women the symptoms are more than a minor irritation. Interrupted sleep, pain after eating and reflux that worsens as pregnancy progresses can genuinely affect quality of life.
Omeprazole is one of the treatments a prescriber may consider when simpler measures have not been effective. It is also one of the most searched-for medicines among pregnant women in the UK, and unfortunately one of the most poorly explained online.
This guide sets out what the UK evidence actually says, where omeprazole sits in the treatment pathway, and what your prescriber will want to discuss with you.
Is Omeprazole Safe in Pregnancy?
The short answer: Omeprazole is commonly used during pregnancy, and UK specialist sources consider it the preferred proton pump inhibitor when a PPI is clinically indicated.
The UK Teratology Information Service (UKTIS), which produces the BUMPS patient leaflets used by the NHS, states plainly that omeprazole is the PPI preferred for use in pregnancy because there is more information about its safety, though other PPIs can also be used if a doctor advises it.
On the question that worries most people, the same source is direct. Omeprazole is commonly used during pregnancy, and available evidence does not indicate that omeprazole or other PPIs are associated with an increased risk of miscarriage, birth defects, stillbirth, preterm delivery, or low birth weight.
This is an important finding. It is not a guarantee, and no medicine in pregnancy comes with one, but it reflects a substantial body of UK-assessed evidence rather than a marketing claim.
Understanding background risk of birth defects
This context is important because it helps explain the advice more clearly, but many articles leave it out.
Miscarriage occurs in around 1 in 5 pregnancies, and around 1 in 40 babies are born with a birth defect. This is the background risk, and it applies whether or not medication is taken.
If something goes wrong in a pregnancy where omeprazole was taken, the medicine is not automatically the explanation. Background risk exists in every pregnancy. Understanding this makes it far easier to weigh a treatment decision rationally rather than anxiously.
The honest caveat
Good evidence-based guidance includes the uncertainties, not just the reassurance.
Some studies, though not all, have suggested a possible association between acid-reducing medicines taken during pregnancy and allergy or asthma in children. Further research is needed to determine whether this association is causal. Reassuringly, those studies all showed that the vast majority of exposed children did not develop allergies or asthma.
There has also been discussion in the medical literature regarding first-trimester exposure and the risk of congenital malformations. UKTIS addresses this issue directly: although one large meta-analysis indicated an increased risk of any malformation for PPIs as a class, there were methodological flaws in that analysis, and meta-analysis restricted to the highest quality evidence did not indicate an increased malformation risk following first trimester PPI exposure.
In summary, some lower-quality studies suggested a potential signal, but higher-quality evidence has not confirmed an increased risk.
What About the "Pregnancy Category B" Label?
You will see a great many websites, including UK ones, describe omeprazole as "pregnancy category B". This is worth correcting, because it is one of the most persistent pieces of misinformation on this topic.
The A/B/C/D/X letter system was a former US FDA classification system. The FDA retired it in 2015, replacing it with the Pregnancy and Lactation Labeling Rule, which requires narrative risk summaries instead of letter grades. The letters were withdrawn precisely because they were routinely misread as a safety ranking, which they were never intended to be.
The UK has never used the letter system at all. British prescribing decisions draw on the BNF, the Summary of Product Characteristics, UKTIS monographs and NICE guidance.
So if you are searching for the omeprazole pregnancy category, the accurate answer is that no current UK or US category applies. What matters is the individual benefit-risk assessment your prescriber makes with you.
When Might a Prescriber Consider Omeprazole?
Omeprazole is not a first step. UK practice follows a clear escalation pathway.
NICE guidance for antenatal care recommends that pregnant women with new or pre-existing heartburn or acid reflux are given information about lifestyle and dietary changes, and that antacids and alginate-based reflux suppressants are considered for treating heartburn in pregnancy, supported by evidence that antacids relieved heartburn compared with placebo without increased gastrointestinal side effects.
Acid-suppressing medicines such as omeprazole, which reduce stomach acid production, may be considered when these measures do not provide adequate symptom control. It is used to treat gastro-oesophageal reflux disease (GORD), indigestion, and related acid reflux symptoms, and can be effective for easing discomfort when simpler measures have not worked. Omeprazole crosses the placenta during pregnancy, which is why prescribers weigh benefits and risks before recommending it.
Situations where a prescriber may consider a PPI include:
- Reflux that persists despite lifestyle changes and an antacid or alginate
- Symptoms severe enough to disturb sleep or interfere with eating
- Diagnosed oesophagitis or oesophageal inflammation
- Existing peptic ulcer disease. PPIs are generally considered the preferred treatment for treating a stomach ulcer in pregnancy, because there is less safety information about the alternatives
- Pre-existing GORD already being managed with a PPI before conception
Symptoms commonly intensify in the second and third trimesters, as hormonal changes relax the lower oesophageal sphincter and the growing uterus increases pressure on the stomach. Many women find that their reflux symptoms worsen during this stage of pregnancy.
The acid reflux treatment pathway at a glance
| Step | Approach | Typical role |
|---|---|---|
| 1 | Lifestyle and dietary changes | First-line at any stage, especially first trimester |
| 2 | Antacids or alginates | First-line medicines, available over the counter |
| 3 | Acid-suppressing medicine (PPI or H2 blocker) | Considered when steps 1 and 2 give inadequate control |
| 4 | Specialist referral | Where red-flag symptoms or complications are present |
Your position within this treatment pathway should be determined through clinical assessment.
Omeprazole in the First Trimester
The first trimester attracts the most anxiety, since it is when organ development takes place.
Current UK assessment does not identify an increased malformation risk from first-trimester omeprazole exposure once study quality is accounted for, as set out above. Some studies reported major malformations in approximately 4% of pregnancies exposed to omeprazole, but this did not show a clear increase above background risk. Standard prescribing principle in pregnancy nonetheless favours the lowest effective dose for the shortest necessary period, particularly in the first trimester.
If you took omeprazole before you knew you were pregnant, that is a common situation and not a reason to panic. Tell your GP or midwife, and let them advise. You should not stop taking a PPI unless your doctor has asked you to.
Abruptly stopping a PPI can lead to rebound acid symptoms and should only be done following clinical advice.
Omeprazole Dosage in Pregnancy
There is no single recommended dose of omeprazole for everyone during pregnancy.
Dosing in pregnancy depends on your symptoms, your trimester, your medical history, whether you were already established on treatment, what you have already tried, and your other medicines. Your healthcare professional can advise on the most appropriate treatment for your individual circumstances.
What can you expect?
When omeprazole is prescribed treatment is tailored to your individual needs. In general, healthcare professionals aim to
- Use the lowest dose that controls symptoms
- Continue treatment only for as long as it is clinically appropriate.
- Review the response.
- Adjust their dose independently during pregnancy.
Your prescriber will determine the appropriate treatment and dose for your circumstances following a clinical assessment. If you have been given a dose and are unsure about it, speak to your prescriber, GP, midwife or pharmacist rather than adjusting it yourself.
How Long Can You Take Omeprazole While Pregnant?
There is no fixed maximum duration that applies to everyone.
For pregnancy-related reflux that appeared during pregnancy, treatment is often short-term and stops after birth, since symptoms typically resolve once the pregnancy ends. Some NHS formulary guidance describes treatment continuing for the duration of symptoms in pregnancy rather than for a fixed course.
For women with pre-existing GORD or ulcer disease, longer-term treatment through pregnancy may be entirely appropriate. Stopping a medicine that is managing a genuine condition carries its own risk.
With longer-term omeprazole use, prescribers may also consider the potential for reduced absorption of certain nutrients, including low vitamin B12 and magnesium absorption.
The practical answer is that duration should be reviewed with your prescriber rather than decided by a calendar.
Omeprazole and Breastfeeding
Omeprazole passes into breast milk in small quantities. The amount reaching a breastfed infant is generally very low and is not expected to cause adverse effects.
This is worth knowing during pregnancy rather than after, because it means treatment that works for you now does not automatically have to stop when your baby arrives. Confirm the plan with your midwife, health visitor, prescriber or healthcare provider, who can review it alongside anything else you are taking.
Alternatives to Omeprazole in Pregnancy
Omeprazole is one option among several, and it is not automatically the right one for every person.
Non-medication measures
Some women find symptoms improve with lifestyle measures such as avoiding fatty foods, maintaining healthy gestational weight gain, not smoking, and sleeping with the head of the bed raised, which can also help reduce reflux-related discomfort.
Additional measures frequently recommended:
- Smaller, more frequent meals rather than large ones
- Leaving two to three hours between eating and lying down
- Identifying and avoiding your personal trigger foods, commonly spicy, acidic, fatty or caffeinated items
- Loose clothing around the waist
- Staying upright after meals
Short-term indigestion and acid reflux in pregnancy, while uncomfortable and sometimes painful, do not generally pose a significant health risk, so some women choose not to use treatments at all. Where symptoms are affecting quality of life, the benefits of treatment may outweigh concerns about hypothetical risks.
That decision should be made in discussion with your clinician, especially as symptoms can sometimes overlap with nausea in pregnancy.
Comparing treatment options
| Option | Type | Position in pregnancy | Notes |
|---|---|---|---|
| Antacids | Neutralise stomach acid | First-line medicine | Available over the counter; examples include Gaviscon for fast acid reflux relief |
| Alginates (e.g. Gaviscon, Peptac) | Barrier against reflux | First-line medicine | Particularly useful where reflux symptoms dominate |
| Omeprazole | Proton pump inhibitor | Preferred PPI in pregnancy | Most pregnancy safety data of the PPI class |
| Lansoprazole | Proton pump inhibitor | Alternative PPI | Alternative proton pump inhibitor used instead of omeprazole when advised by a prescriber |
| Pantoprazole | Proton pump inhibitor | Alternative PPI | Used where advised by a prescriber |
| Esomeprazole | Proton pump inhibitor | Alternative PPI | Can also be used instead of omeprazole when clinically appropriate |
| Famotidine | H2 receptor antagonist | Alternative acid suppressant | Different mechanism to PPIs and other acid-suppressing drugs |
No entry in this table is "better" than another in the abstract. Suitability depends entirely on individual clinical assessment.
Brand names you may have searched
Omeprazole is sold under different brand names around the world. In the UK, Losec is a licensed brand of omeprazole,alongside generic omeprazole products. You may also see names such as Omez, Limzer online, but these are marketed in India and some other countries and are not licensed for supply in the UK.
If you have been prescribed omeprazole outside the UK or are moving to the UK, tell your healthcare professional the active ingredient (omeprazole) , strength , and formulation ( for example, capsules or tablets). They can advise whether a UK- licensed equivalent is appropriate.
When to Contact a Healthcare Professional
Contact your GP, midwife or maternity unit promptly if you experience:
- Difficulty or pain when swallowing
- Vomiting blood, or vomit resembling coffee grounds
- Black or tarry stools
- Unintentional weight loss
- Severe or persistent abdominal pain
- Reflux that suddenly worsens or stops responding to treatment
- Severe pain below the ribs on the right side, particularly with headache or visual disturbance, which can indicate pre-eclampsia rather than reflux
For example, severe abdominal pain or persistent vomiting may indicate a condition other than simple reflux, and these symptoms still need assessment even if you are already taking omeprazole.
Upper abdominal pain in later pregnancy is not always indigestion, and pre-eclampsia can present in a way that is easily mistaken for heartburn. If pain is severe or accompanied by headache, visual changes or swelling, seek urgent advice rather than reaching for an antacid.
Will my baby need extra monitoring?
Most women are offered an anomaly scan at around 20 weeks as part of routine antenatal care. No additional monitoring is required following use of a PPI.
What if my partner takes proton pump inhibitors (PPIs)?
No increased risk to the baby would be expected if the father takes a PPI. Available evidence does not suggest that PPI use around conception adversely affects male fertility or sperm quality.
Getting Treatment Through EveryDayMeds
We are a GPhC-registered UK pharmacy. Every order is reviewed by an independent prescriber before any medicine is supplied.
How the process works
- Complete a short online assessment covering your symptoms, medical history and pregnancy status
- An independent prescriber reviews your answers
- Where treatment is appropriate, you select from suitable options
- Your medicine is dispensed and delivered
Assessments take around two minutes to complete and are entirely online.
A note on pregnancy specifically. Declaring your pregnancy on the assessment is essential. It changes what can safely be prescribed and how the request is reviewed. Our prescribers may decline to supply and recommend you speak to your GP or midwife instead, particularly where symptoms suggest something requiring in-person assessment. That is the system working correctly rather than failing.
Pricing-The price shown at checkout is what you pay, with no separate prescriber fee added afterwards.
Key Takeaways
- Omeprazole is the PPI with the most pregnancy safety data and is the preferred PPI choice in UK guidance when one is needed
- UK sources find no good evidence linking PPIs to miscarriage, birth defects, stillbirth, preterm delivery or low birth weight
- The "pregnancy category B" label is a retired US classification that has never applied in the UK
- Lifestyle measures, then antacids or alginates such as Gaviscon, may relieve symptoms before moving to a PPI
- Omeprazole is used to treat GORD, gastroesophageal reflux disease, indigestion, and acid reflux symptoms when simpler options are not enough
- Never stop or change a prescribed PPI without clinical advice
- Omeprazole is generally considered compatible with breastfeeding
- Background risk exists in every pregnancy regardless of medication
Medical Disclaimer
This article is for general information and does not replace personalised medical advice. It should not be used to self-diagnose, self-prescribe, or change any prescribed treatment. Omeprazole and other acid-suppressing medicines should only be used in pregnancy under the supervision of an appropriately qualified prescriber. Treatment suitability depends on individual clinical assessment, and responses vary between individuals. If you are pregnant, breastfeeding, or planning a pregnancy, speak to your GP, midwife, pharmacist or prescriber before starting, stopping or changing any medicine. Seek urgent medical advice for any red-flag symptom listed above.
